Financial projections

Barkan-Farma is pursuing a great market opportunity. The unmet needs of the rapidly growing Eastern European and Central Asia regions markets together with a wide range of unique ethical drugs and highly-popular OTC products provide excellent prospects for Barkan-Farma to become a highly profitable venture.

Barkan-Farma intends to raise US$ 1 million in equity investment. The Company estimates that the investment will finance the execution of the clinical development and registration programs in the next five years including: (i) clinical trials for Ravirin in Moldova and submission of the regulatory approval files, (ii) initial promotion and advertisement programs for the approved drugs, (iii) market launch campaigns for the cosmetics products in Moldova, and (iv) finding potential distributors in other Eastern European countries.

The following projected statement of operations depicts Barkan-Farma's estimated phased growth through 2013:

The projected profit and loss forecast is based on the following assumptions: